# OKYO Pharma Limited (OKYO)

> Healthcare · GB · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OKYO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -4.72M | $ -3.17M | $ 185.8K | $ -3.42M |
| 2024 | $ 0 | $ -2.83M | $ -256.6K | $ 1.8K | $ -7.23M |
| 2023 | $ 0 | $ -17.9K | $ -11.9K | $ 0 | $ -2.05M |
| 2022 | $ 0 | $ -6.44M | $ -2.61M | $ 0 | $ -345.8K |
| 2021 | $ 0 | $ -3.33M | $ -4.95M | $ 81.5K | $ 4.94M |
| 2020 | $ 0 | $ -2.05M | $ -1.11M | $ 29.0K | $ 7.07M |
| 2019 | $ 0 | $ -1.42M | $ -1.34M | $ 0 | $ -195.8K |
| 2018 | $ 0 | $ -1.4K | $ -1.2K | $ 0 | $ 1.42M |
| 2017 | $ 0 | $ -13.0K | $ -408 | $ 0 | $ 3.54M |
| 2016 | $ 0 | $ -279 | $ -154 | $ 0 | $ 28.95M |
| 2015 | $ 0 | $ -3.7K | $ -510 | $ 0 | $ 34.13M |
| 2014 | $ 0 | $ -1.9K | $ -1.2K | $ 0 | $ 44.76M |
| 2013 | $ 0 | $ -5.6K | $ -1.7K | $ 0 | $ 37.80M |
| 2012 | $ 0 | $ -1.1K | $ -1.1K | $ 0 | $ 48.90M |
| 2011 | N/A | N/A | N/A | $ 0 | $ 16.01M |
| 2010 | N/A | N/A | N/A | $ 0 | $ 15.76M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.05 |
| Liabilities / Eq | -2.36 |
| Current Ratio | 0.58 |

## Other views

- [Metrics](https://sponda.capital/en/OKYO.md)
- [Charts](https://sponda.capital/en/OKYO/charts.md)
- [Compare](https://sponda.capital/en/OKYO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.